NAV4/16/2021 Chg.-4.7700 Type of yield Investment Focus Investment company
985.5600USD -0.48% reinvestment Equity Worldwide Pictet AM (EU) 
 

Investment goal

The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Biotechnology
Benchmark: MSCI World
Business year start: 10/1
Last Distribution: -
Depository bank: Pictet & Cie (Europe) S.A.
Fund domicile: Luxembourg
Distribution permission: Austria, Germany, Switzerland, United Kingdom
Fund manager: Tazio Storni, Lydia Haueter
Fund volume: 2.35 bill.  USD
Launch date: 11/30/1995
Investment focus: -

Conditions

Issue surcharge: 5.00%
Max. Administration Fee: 1.60%
Minimum investment: 0.00 USD
Deposit fees: 0.30%
Redemption charge: 3.00%
Ongoing charges (12/31/2020): 2.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Pictet AM (EU)
Address: 15, avenue J. F. Kennedy, 1855, Luxemburg
Country: Luxembourg
Internet: www.am.pictet/de/germany
 

Assets

Stocks
 
96.06%
Cash
 
3.94%

Countries

United States of America
 
89.68%
Cash
 
3.94%
Canada
 
2.61%
China
 
1.93%
Denmark
 
0.83%
Netherlands
 
0.59%
Ireland
 
0.28%
Germany
 
0.14%

Branches

Healthcare
 
84.96%
IT/Telecommunication
 
8.02%
Cash
 
3.94%
Others
 
3.08%